Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii

被引:73
作者
Bishburg, Eliahu [1 ]
Bishburg, Kathryn [2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Div Infect Dis, Newark, NJ 07112 USA
[2] Middlesex Regulatory Consulting, Highland Pk, NJ USA
关键词
Minocycline; Intravenous; Acinetobacter infection; MRSA; IN-VITRO ACTIVITY; SOFT-TISSUE INFECTIONS; BLOOD-STREAM INFECTION; TRIAL TEST PROGRAM; ANTIMICROBIAL SUSCEPTIBILITY; TETRACYCLINE RESISTANCE; TIGECYCLINE EVALUATION; UNITED-STATES; RIBOSOMAL-RNA; PHARMACOKINETICS;
D O I
10.1016/j.ijantimicag.2009.06.021
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The epidemiology of nosocomial and community-acquired infections has changed in recent years. Methicillin-resistant Staphylococcus aureus (MRSA), especially community-associated MRSA (CA-MRSA), has emerged as a Gram-positive organism with an increasing impact in clinical practice. Infections with Acinetobacter baumannii have become a major cause of morbidity and mortality. Minocycline has significant in vitro activity against MRSA and A. baumannii that is comparable with agents currently used against these organisms. The absence of an intravenous (i.v.) minocycline formulation in recent years has limited its use in seriously ill patients infected with these organisms. However, minocycline i.v. has recently been reintroduced to the US market. The objective of this study was to review available information on the chemistry, mechanism of action, in vitro activity, resistance mechanisms, pharmacokinetics, tolerability and efficacy of minocycline against MRSA and A. baumannii. This article provides suggestions for future studies and potential uses of minocycline and is designed to trigger interest in systematic clinical evaluation of minocycline for patients infected with these organisms. In conclusion, minocycline is an old drug that has the potential to become an important part of the armamentarium against emerging infections such as CA-MRSA and A. baumannii. Owing to its promising profile against these clinically important pathogens as well as excellent pharmacokinetic properties, minocycline merits evaluation in serious infections. (C) 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 82 条
[31]   Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial [J].
Halstead, Diane C. ;
Abid, Joan ;
Dowzicky, Michael J. .
JOURNAL OF INFECTION, 2007, 55 (01) :49-57
[32]   Susceptibility of Acinetobacter strains isolated from deployed US military personnel [J].
Hawley, Joshua S. ;
Murray, Clinton K. ;
Griffith, Matthew E. ;
McElmeel, M. Leticia ;
Fulcher, Letitia C. ;
Hospenthal, Duane R. ;
Jorgensen, James H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (01) :376-378
[33]   In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004) [J].
Hoban, DJ ;
Bouchillon, SK ;
Johnson, BM ;
Johnson, JL ;
Dowzicky, MJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :215-227
[34]   Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002 [J].
Jerassy, Z ;
Yinnon, AM ;
Mazouz-Cohen, S ;
Benenson, S ;
Schlesinger, Y ;
Rudensky, B ;
Raveh, D .
JOURNAL OF HOSPITAL INFECTION, 2006, 62 (02) :230-236
[35]  
JONAS M, 1982, THER DRUG MONIT, V4, P137
[36]   Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. [J].
Jones, Ronald N. ;
Ferraro, Mary Jane ;
Reller, L. Barth ;
Schreckenberger, Paul C. ;
Swenson, Jana M. ;
Sader, Helio S. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (01) :227-230
[37]   Current control and treatment of multidrug-resistant Acinetobacter baumannii infections [J].
Karageorgopoulos, Drosos E. ;
Falagas, Matthew E. .
LANCET INFECTIOUS DISEASES, 2008, 8 (12) :751-762
[38]   New uses of older antibiotics [J].
Klein, NC ;
Cunha, BA .
MEDICAL CLINICS OF NORTH AMERICA, 2001, 85 (01) :125-+
[39]   Invasive methicillin-resistant Staphylococcus aureus infections in the United States [J].
Klevens, R. Monina ;
Morrison, Melissa A. ;
Nadle, Joelle ;
Petit, Susan ;
Gershman, Ken ;
Ray, Susan ;
Harrison, Lee H. ;
Lynfield, Ruth ;
Dumyati, Ghinwa ;
Townes, John M. ;
Craig, Allen S. ;
Zell, Elizabeth R. ;
Fosheim, Gregory E. ;
McDougal, Linda K. ;
Carey, Roberta B. ;
Fridkin, Scott K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (15) :1763-1771
[40]   TREATMENT OF PROSTHETIC VALVE ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS WITH MINOCYCLINE [J].
LAWLOR, MT ;
SULLIVAN, MC ;
LEVITZ, RE ;
QUINTILIANI, R ;
NIGHTINGALE, C .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :812-814